Mast cells are resident immune cells in the thalamus that can degranulate and release hundreds of signaling molecules (i.e., monoamines, growth factors, and cytokines) both basally and in response to environmental stimuli. Interestingly, mast cell numbers in the brain show immense individual variation in both rodents and humans. We used a Pavlovian conditioned approach (PCA) procedure to examine whether mast cells are associated with individual variation in the attribution of incentive-motivational value to reward-related cues. During the PCA procedure, a lever response-independently predicts the delivery of a food pellet into a magazine, and over training sessions three conditioned responses (CRs) develop: sign-tracking (lever-directed CRs), goal-tracking (magazine-directed CRs), and an intermediate response (both CRs). In Experiment 1, we measured thalamic mast cell number/activation using toluidine blue and demonstrated that sign-trackers have increased degranulated (activated) but not granulated (inactive) mast cells. In Experiment 2, we infused the mast cell inhibitor, cromolyn (200 mg/rat; i.c.v.), immediately before five daily PCA training sessions and demonstrated that mast cell inhibition selectively impairs the acquisition of sign-tracking behavior. Taken together, these results demonstrate that thalamic mast cells contribute to the attribution of incentive-motivational value to reward-related cues and suggest that mast cell inhibition may be a novel target for addiction treatment.
Introduction
Mast cells are a heterogeneous population of immune cells that are generated as precursor cells in the periphery within bone marrow and can rapidly penetrate the blood vessels of the blood-brain barrier where they mature within the brain (Silverman et al., 2000) . Mast cells have been identified in the brains of approximately two dozen mammalian species, including both rats and humans (Dropp, 1976 (Dropp, , 1979 . Within the brains of rats, they reside primarily within the thalamus and epithalamus (Goldschmidt et al., 1984) where they degranulate (Persinger, 1983) and release hundreds of signaling molecules (i.e., monoamines, growth factors, and cytokines) in a radius up to 50 mm (Nautiyal et al., 2008) . Degranulation can amplify signaling by affecting the activity of a wide variety of surrounding cells, including neurons (Koszegi et al., 2006; Kovacs et al., 2006) , astrocytes (Zeng et al., 2013) , and microglia (Yuan et al., 2010; Zhang et al., 2012) . Moreover, mast cells are poised to dynamically influence behavior, because their number and activity within the thalamus is highly variable under basal conditions (Florenzano and Bentivoglio, 2000, 2001) , fluctuate in response to physiological states and environmental stimuli, and show behaviorally relevant patterns of regional activation (Asarian et al., 2002; Kovacs and Larson, 2006) . In addition, mast cells contribute approximately 90% of thalamic histamine in rodents (Goldschmidt et al., 1985) , and histamine has been implicated in appetitive behaviors and motivational processes (Torrealba et al., 2012) . Although mast cells in the brain have been previously linked to depression-and anxiety-like behaviors (Chikahisa et al., 2013; Nautiyal et al., 2008) , it is currently unknown whether mast cells play a role in reward-related behaviors.
Interestingly, there is substantial individual variation in the number of brain mast cells. For example, in male Sprague Dawley rats, brain mast cell numbers can vary from 1,490 to 19,103 per whole brain (Goldschmidt et al., 1984) , and human mast cells can vary from 0 to 49,000 depending on the brain region (Dropp, 1979) . Given this high variability in mast cell numbers, mast cells could contribute substantially to individual variation in rewardrelated behaviors that are relevant to vulnerability and resilience
